Granules India Ltd. (GRANULES): Granules India Share Price Rises 3.79% Today, Among Top Gainers

Granules India Ltd. traded at Rs 869.95, up 3.79% today, taking its market capitalisation to Rs 20,923.97 crore and placing the stock among notable gainers in the session.

Granules India Share Price was at Rs 869.95 on 07 August 2026 at 1:28:28 PM IST, up Rs 31.75 or 3.79% from the previous close of Rs 838.20. With a market capitalisation of Rs 20,923.97 crore, the stock stood out in today’s trade as a large-cap name registering a meaningful same-day price rise. For investors tracking Granules India Share Price Today, the move drew attention because it combined a clear gain with a fresh intraday high of Rs 872.00.

The supplied data confirms the price event, the intraday range and the turnover, but it does not establish a company-specific catalyst behind the move. That makes today’s stock news more about verified market action than about a confirmed trigger. Even so, a rise of 3.79% in a company of this size is enough to place Granules India Stock News firmly on the radar of traders and long-term market watchers looking at Top Gainers Today.

In the broader context of Stock Market Today and Share Market Today, the data shows a stock that opened at Rs 835.50, never slipped below that level during the session, and moved as high as Rs 872.00. Univest notes that this kind of intraday profile often attracts attention because it reflects sustained buying interest through the day rather than a brief spike. The next step is to examine what the price action, sector context and peer positioning say about the move.

Granules India Ltd. (GRANULES) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 869.95
Previous Close	Rs 838.2
Today's Change	+Rs 31.75 (+3.79%)
Day Open	Rs 835.5
Day High	Rs 872
Day Low	Rs 835.5
Current Volume (BSE)	11,110
BSE Traded Volume	11,110
NSE Traded Volume	4,65,306
Combined NSE + BSE Volume	4,76,416
Turnover	Rs 0.97 crore
Market Capitalisation	Rs 20,923.97 crore
Market Cap Category	Large Cap

Granules India Ltd. (GRANULES) traded at Rs 869.95. versus the previous close of Rs 838.2, a rise of 3.79%. The stock opened at Rs 835.5, reached Rs 872, touched Rs 835.5. Reported volume was 11,110.

Granules India Ltd. (GRANULES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 20,923.97 crore

Granules India Fundamental Analysis is constrained to the company-level data that is actually supplied, but even that limited set provides useful context. The key confirmed figure is market capitalisation of Rs 20,923.97 crore, which places Granules India in a significantly larger bracket than many Healthcare names listed in the benchmark universe used in the sector snapshot.

Market capitalisation is a size measure rather than a quality score, yet it still matters when evaluating a same-day share price gain. A stock with a market cap above Rs 20,000 crore typically requires broader market participation to sustain a 3.79% move than a smaller stock does. That does not prove a fundamental re-rating on its own, but it does make Granules India Share Price News more relevant for investors who track larger Healthcare counters rather than only small and micro-cap momentum names.

The company’s market value also stands well above the Healthcare benchmark statistics provided. In the same-sector universe of 198 companies, the median market capitalisation is Rs 140.58 crore and the average is Rs 471.12 crore, while the maximum in the supplied benchmark list is Rs 3,060.41 crore. Against that backdrop, Granules India Market Cap of Rs 20,923.97 crore sits far beyond the benchmark range shown here. That gap does not by itself indicate valuation richness or cheapness, but it does underline scale.

From a financial-analysis perspective, today’s move is therefore easier to interpret as a significant market event simply because of company size. Granules India Share Price Today did not just edge higher; it added value on a base that is already large in absolute terms. Univest would frame that as a point of context rather than a conclusion. Without supplied company-specific valuation multiples, profitability ratios or earnings metrics, the most grounded fundamental takeaway is that the stock’s size amplifies the significance of the day’s price rise. The next question is how that size sits inside the Healthcare sector and against directly supplied peers.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.27x
Benchmark Average P/E	92.32x
Benchmark P/E Range	3.3x to 3,493.04x
Benchmark Median P/B	1.95x
Benchmark Median ROE	10.77%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 20,923.97 crore
Benchmark Median Market Cap	Rs 140.58 crore

Granules India Ltd. (GRANULES) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector snapshot shows a wide valuation and profitability spread across companies in the same sector. That makes sector context important for understanding why Granules India Share Price is drawing attention today, especially because the company’s market capitalisation is far above the benchmark averages supplied for the peer universe.

The supplied sectorSnapshot places Granules India within the Healthcare sector. The benchmark scope is described as the same sector, and it covers 198 companies. Within that set, P/E data is available for 156 companies, where the median is 26.27, the average is 92.32, the minimum is 3.30 and the maximum is 3,493.04. P/B data is available for 197 companies, with a median of 1.95 and an average of 2.55, while the range runs from -21.27 to 16.42. ROE data for 197 companies shows a median of 10.77 and an average of 15.32. ROCE for 197 companies has a median of 13.35 and an average of 17.69.

These sector numbers matter because they show how dispersed the Healthcare pack is. A very high average P/E relative to the median indicates that a few extreme valuations are pulling the mean upward. In contrast, the median values for P/E, P/B, ROE and ROCE offer a more stable reference point for how a typical stock in this group is valued and how it performs operationally. Granules India Stock Analysis therefore has to be read with care: the broader Healthcare universe includes companies with very different profitability and valuation profiles.

The market-cap benchmark also highlights scale differences. Across the same 198-company scope, the median market cap is Rs 140.58 crore and the average is Rs 471.12 crore, with the supplied maximum at Rs 3,060.41 crore. Against that benchmark, Granules India Share Price News today is attached to a company that is much larger than the sector sample figures listed. Univest sees this as an important context point for market watchers: when a larger Healthcare name becomes one of the Stocks in News, the move often gets more attention than a similar percentage gain in a smaller stock because the capital base is much larger.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,060.41	31.3	0.46	-2.89	-0.26
Hikal Ltd.	HIKAL	2,862.43	0	2.29	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,652.52	40.87	8.32	28.21	26.35
Beta Drugs Ltd.	BETA	2,623.92	67.31	10.65	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,571.92	0	3.06	0	5.36

Granules India Ltd. (GRANULES) has a market capitalisation of Rs 20,923.97 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The direct peer list supplied for Granules India consists mostly of Healthcare and Pharmaceuticals & Drugs names, with one Hospital & Healthcare Services company. Even without complete company-level valuation data for Granules India itself, the peer set still helps show where its market size stands relative to listed names in the same broad sector.

The peer snapshot includes Dishman Carbogen Amcis Ltd. with a market cap of Rs 3,060.41 crore, Hikal Ltd. at Rs 2,862.43 crore, Kwality Pharmaceuticals Ltd. at Rs 2,652.52 crore, Beta Drugs Ltd. at Rs 2,623.92 crore and Panacea Biotec Ltd. at Rs 2,571.92 crore. It also includes Dr Agarwals Eye Hospital Ltd. at Rs 2,537.31 crore, Solara Active Pharma Sciences Ltd. at Rs 2,481.41 crore, Sai Parenteral's Ltd. at Rs 2,290.47 crore, Fredun Pharmaceuticals Ltd. at Rs 2,171.94 crore and NGL Fine-Chem Ltd. at Rs 2,127.68 crore.

On market capitalisation alone, Granules India Ltd. at Rs 20,923.97 crore is several times larger than every supplied peer. That is the cleanest and most verifiable comparison available in the data. The peer group also illustrates how varied sector metrics can be: Dishman Carbogen Amcis has a P/E of 31.30 with ROE of -2.89 and ROCE of -0.26, while Kwality Pharmaceuticals shows a P/E of 40.87, ROE of 28.21 and ROCE of 26.35. Beta Drugs trades at a P/E of 67.31 with ROE of 18.65 and ROCE of 22.17, and NGL Fine-Chem carries a P/E of 44.10 with ROE of 27.90 and ROCE of 33.91.

The takeaway for Granules India Share Price Today is not that it can be directly ranked on every metric here, because that would require company-specific P/E, P/B, ROE and ROCE values that are not part of the supplied dataset. The reliable conclusion is narrower and factual: compared with these listed peers, Granules India commands much greater market scale, and that makes its 3.79% price rise more visible within Healthcare market news.

Why Investors Are Watching Granules India

Investors are watching Granules India Share Price because today’s move combines a notable percentage gain with large-cap scale. In a session where market participants track Top Gainers Today and Stocks Rising Today, a 3.79% rise in a Rs 20,923.97 crore company naturally attracts attention. Granules India Stock News is also being watched because the stock opened at the day’s low and then held a firm upward path toward Rs 872.00.

• Verified price action: The stock rose Rs 31.75 to Rs 869.95 from the previous close of Rs 838.20.
• Intraday strength: The day low and opening price were both Rs 835.50, while the day high reached Rs 872.00.
• Volume context: Total volume stood at 4,76,416 shares, with 4,65,306 shares on NSE and 11,110 shares on BSE.
• Scale factor: Market capitalisation is Rs 20,923.97 crore, making the move notable in a large-cap stock.
• Sector lens: The company sits in Healthcare, where benchmark valuation and profitability metrics vary widely across 198 companies.

What investors may monitor next is whether Granules India Share Price continues to hold close to the upper end of today’s range and whether the stock remains prominent in ongoing Granules India Latest News and market updates. Univest would also watch how the move is interpreted relative to broader Healthcare sector trading, peer positioning and follow-through participation across NSE and BSE.

About Granules India

Granules India Ltd. is the company at the centre of today’s Granules India Share Price rise. The supplied data identifies the company by name and symbol, GRANULES, and places it within the Healthcare sector. That classification is important because it frames the stock inside one of the largest and most closely tracked parts of the Indian stock market.

The peer and benchmark data linked to the company are dominated by Pharmaceuticals & Drugs businesses, along with one Hospital & Healthcare Services company. While the supplied dataset does not provide a formal company description, product profile or segment-level revenue mix for Granules India Ltd., it does place the stock in a sector that investors typically evaluate through valuation, profitability and market-cap comparisons. In that sense, Granules India Share Price Update today is being read not only as a standalone market event, but also as part of a wider Healthcare sector screen.

At Rs 20,923.97 crore in market capitalisation, Granules India is much larger than the benchmark company sizes listed in the same sector snapshot and the direct peer set supplied here. That larger scale can influence how the market interprets today’s move. For investors following Granules India NSE and Granules India BSE activity, the company therefore stands out as a sizable Healthcare stock whose price action can draw attention even without a separately confirmed company-specific trigger in the supplied data.

Track Granules India Share Price on Univest

Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who want to follow Granules India Share Price in real time can use Univest to monitor live share price moves, intraday ranges and broader stock analysis in one place. Granules India Share Price Today, Granules India Share News and Granules India Stock Performance are often best understood when price action is viewed alongside market capitalisation, sector context and peer comparison.

On Univest, users can track Granules India Share Price Live, 52-week levels when available, market insights, company ratios, shareholding pattern updates when disclosed, and continuing market news across NSE and BSE. That makes it easier to place a one-day move like today’s 3.79% gain into a broader research framework without jumping to conclusions from price action alone.

Frequently Asked Questions

Why is Granules India Share Price in focus today?

Ans. Granules India Share Price is in focus because the stock rose 3.79% to Rs 869.95 from the previous close of Rs 838.20. For a large-cap Healthcare company with Rs 20,923.97 crore market capitalisation, that is a notable same-day move.

What is Granules India Share Price Today?

Ans. Granules India Share Price Today was Rs 869.95 at 1:28:28 PM IST on 07 August 2026. The stock was up Rs 31.75, or 3.79%, versus its previous close of Rs 838.20 during the session.

How much did Granules India stock rise today?

Ans. Granules India stock rose by Rs 31.75 today, which equals a 3.79% gain over the previous close. The move lifted the stock from Rs 838.20 to Rs 869.95 and placed it among notable gainers in trade.

What were the day high and day low for Granules India shares?

Ans. Granules India shares touched an intraday high of Rs 872.00 and a day low of Rs 835.50. The opening price was also Rs 835.50, showing that the stock strengthened after the session began and stayed above the open.

What was the opening price of Granules India today?

Ans. Granules India opened at Rs 835.50 today, compared with a previous close of Rs 838.20. Since the day low was also Rs 835.50, the stock did not trade below its opening level during the reported session.

What is the market capitalisation of Granules India?

Ans. The market capitalisation of Granules India was Rs 20,923.97 crore in the supplied data. That makes it much larger than the Healthcare benchmark median of Rs 140.58 crore and average of Rs 471.12 crore.

How much volume was traded in Granules India shares today?

Ans. Total traded volume in Granules India shares was 4,76,416. Of this, NSE volume was 4,65,306 and BSE volume was 11,110. The turnover figure supplied for the referenced exchange was Rs 0.97 crore.

Which sector does Granules India belong to?

Ans. Granules India is classified in the Healthcare sector in the supplied data. The benchmark scope covers 198 same-sector companies, making sector comparison relevant when evaluating today’s Granules India Share Price rise.

How does Granules India compare with the supplied Healthcare peers by size?

Ans. By market capitalisation, Granules India at Rs 20,923.97 crore is far larger than the supplied peers, which range from Rs 2,127.68 crore for NGL Fine-Chem to Rs 3,060.41 crore for Dishman Carbogen Amcis.

What should investors monitor after today’s Granules India Share Price rise?

Ans. Investors may monitor whether Granules India holds near today’s upper trading band after reaching Rs 872.00. Ongoing volume participation, broader Healthcare sector movement and follow-through in Granules India Stock News are the key factual checkpoints.